News
23h
GlobalData on MSNValneva reports data from Phase II chikungunya vaccine trial in childrenValneva has reported encouraging six-month safety and antibody persistence data from the multi-centre Phase II trial, VLA1553 ...
21hon MSN
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results